UnknownPhase 4

Comparison of Standard and Minidose Spinal Anesthesia for Cesarean Section Operation Using Marcaine Spinal 0.5% Heavy

Israel100 participantsStarted 2011-02

Plain-language summary

The objectives of this study is to test a combination of low dose local anesthetic Bupivacaine diluted in patient's CSF with lipophilic opiate Fentanyl for optimal spinal anesthesia during Cesarean Section. The dilution of Bupivacaine with CSF in our study would result in effective spinal anesthesia with relatively limited motor block, quick recovery of motor function and relatively long lasting analgesia. We expect lower incidence of side effects with this combination than with convenient dose of Bupivacaine.

Who can participate

Age range18 Years – 40 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women over 38 weeks of pregnancy, who read and write Hebrew * ASA class I and II * Age between 18 and 40 years * Weight 50-100 kg * Elective Cesarean Section for singlet pregnancy Exclusion Criteria: * Previous history of two or more Cesarean Sections * Contraindications for regional anesthesia * Active pain before surgery * Non singlet pregnancy

What they're measuring

prominence of motor blockade

Timeframe: up to 2 h

Trial details

NCT IDNCT01303731

SponsorBnai Zion Medical Center

Sponsor typeOTHER_GOV

Study typeINTERVENTIONAL

Primary completion2012-01

Contact for this trial

Boris Yanovsky, MD

+972 50 626788 boris.yanovsky@b-z.org.il

View on ClinicalTrials.gov More Cesarean Section trials